Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious vaginitis. Selecting therapy and preventing recurrence

M A Goode1, K Grauer, J G Gums

  • 1Department of Hospital Pharmacy Practice and Administration, Medical University of South Carolina, Charleston.

Postgraduate Medicine
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?

Clinical and translational science·2016
Same author

Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide.

The pharmacogenomics journal·2014
Same author

Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate.

Clinical pharmacology and therapeutics·2014
Same author

Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.

Journal of internal medicine·2014
Same author

Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.

The pharmacogenomics journal·2013
Same author

Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.

The pharmacogenomics journal·2012

Managing recurrent vaginal infections like candidiasis, trichomoniasis, and bacterial vaginosis requires addressing contributing factors alongside drug therapy. Both topical and oral treatments are effective, with specific considerations for pregnant women and partner management.

Area of Science:

  • Gynecology
  • Infectious Diseases
  • Pharmacology

Background:

  • Recurrent vaginal infections, including vaginal candidiasis, trichomoniasis, and bacterial vaginosis, present significant management challenges.
  • Predisposing factors and frequent recurrence complicate treatment efficacy.

Purpose of the Study:

  • To outline optimal management strategies for common vaginal infections.
  • To emphasize the importance of addressing contributing factors beyond pharmacotherapy.
  • To review treatment options and safety profiles, particularly in pregnant women.

Main Methods:

  • Review of current therapeutic guidelines and clinical evidence for vaginal candidiasis, trichomoniasis, and bacterial vaginosis.
  • Comparison of topical versus oral administration routes for available agents.

Related Experiment Videos

  • Analysis of management recommendations for sexual partners and impact on recurrence.

    • Main Results:

    • Both topical and oral agents demonstrate comparable safety and efficacy for vaginal candidiasis and bacterial vaginosis.
    • Oral therapy is preferred for trichomoniasis, with topical clotrimazole as a pregnancy alternative.
    • Partner treatment is recommended for trichomoniasis and optional for bacterial vaginosis.

    Conclusions:

    • Comprehensive management of vaginal infections necessitates addressing predisposing factors to minimize recurrence.
    • Treatment strategies should be tailored based on the specific infection and patient status, including pregnancy.
    • Further research is needed to clarify the role of male partner treatment in preventing vaginal candidiasis recurrence.